Literature DB >> 10793084

Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).

K Miyamoto1, S Khosrof, S E Bursell, Y Moromizato, L P Aiello, Y Ogura, A P Adamis.   

Abstract

Two prominent vascular endothelial growth factor (VEGF)-induced retinal effects are vascular permeability and capillary nonperfusion. The mechanisms by which these effects occur are not completely known. Using a rat model, we show that intravitreous injections of VEGF precipitate an extensive retinal leukocyte stasis (leukostasis) that coincides with enhanced vascular permeability and capillary nonperfusion. The leukostasis is accompanied by the up-regulation of intercellular adhesion molecule-1 expression in the retina. The inhibition of intercellular adhesion molecule-1 bioactivity with a neutralizing antibody prevents the permeability and leukostasis increases by 79% and 54%, respectively. These data are the first to demonstrate that a nonendothelial cell type contributes to VEGF-induced vascular permeability. Additionally, they identify a potential mechanism for VEGF-induced retinal capillary nonperfusion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10793084      PMCID: PMC1876909          DOI: 10.1016/S0002-9440(10)65044-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

Authors:  A P Adamis; J W Miller; M T Bernal; D J D'Amico; J Folkman; T K Yeo; K T Yeo
Journal:  Am J Ophthalmol       Date:  1994-10-15       Impact factor: 5.258

2.  Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.

Authors:  S Schröder; W Palinski; G W Schmid-Schönbein
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

3.  Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor.

Authors:  L P Aiello; S E Bursell; A Clermont; E Duh; H Ishii; C Takagi; F Mori; T A Ciulla; K Ways; M Jirousek; L E Smith; G L King
Journal:  Diabetes       Date:  1997-09       Impact factor: 9.461

4.  Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels.

Authors:  T Murata; T Ishibashi; A Khalil; Y Hata; H Yoshikawa; H Inomata
Journal:  Ophthalmic Res       Date:  1995       Impact factor: 2.892

5.  Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.

Authors:  H Shen; M Clauss; J Ryan; A M Schmidt; P Tijburg; L Borden; D Connolly; D Stern; J Kao
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

6.  Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage.

Authors:  I Kurose; D C Anderson; M Miyasaka; T Tamatani; J C Paulson; R F Todd; J R Rusche; D N Granger
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

7.  Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor.

Authors:  K Iijima; N Yoshikawa; D T Connolly; H Nakamura
Journal:  Kidney Int       Date:  1993-11       Impact factor: 10.612

8.  Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy.

Authors:  F Malecaze; S Clamens; V Simorre-Pinatel; A Mathis; P Chollet; C Favard; F Bayard; J Plouet
Journal:  Arch Ophthalmol       Date:  1994-11

9.  Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury.

Authors:  K J Kelly; W W Williams; R B Colvin; J V Bonventre
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  96 in total

1.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Sugar creates a sticky business: round up the usual suspects.

Authors:  James T Rosenbaum
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 3.  Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research.

Authors:  R Donnelly; I Idris; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

Review 4.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

Review 5.  Vascular endothelial growth factor biology: clinical implications for ocular treatments.

Authors:  R B Bhisitkul
Journal:  Br J Ophthalmol       Date:  2006-12       Impact factor: 4.638

Review 6.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

Review 7.  The pathologic continuum of diabetic vascular disease.

Authors:  Gabriela Orasanu; Jorge Plutzky
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

Review 8.  Therapeutic Options in Refractory Diabetic Macular Oedema.

Authors:  Sanket U Shah; Raj K Maturi
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

9.  Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats.

Authors:  F Mori; T Hikichi; T Nagaoka; J Takahashi; N Kitaya; A Yoshida
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

10.  Genetic loci that control the size of laser-induced choroidal neovascularization.

Authors:  Kei Nakai; Michael S Rogers; Takashi Baba; Taisaku Funakoshi; Amy E Birsner; Dema S Luyindula; Robert J D'Amato
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.